Rgene Corporation
Clinical trials sponsored by Rgene Corporation, explained in plain language.
-
New hope for tough pancreatic cancer? experimental combo enters human testing
Disease control Not yet recruitingThis phase 2 trial tests an experimental oral liquid called BLEX 404 combined with standard chemotherapy (gemcitabine) in 40 people with advanced pancreatic cancer that cannot be removed by surgery or has spread. The study first finds a safe dose, then checks if the combo shrinks…
Phase: PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Mushroom extract BLEX 404 joins chemo in new lung cancer trial
Disease control Not yet recruitingThis early-phase trial tests whether adding BLEX 404, a liquid extract from maitake mushrooms, to standard chemotherapy (pemetrexed + cisplatin) can help people with advanced non-small cell lung cancer that has no EGFR mutation. The study will enroll 32 adults aged 20–70 who have…
Phase: PHASE1, PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC